MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM X; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON
|
Back to Search Results |
|
Model Number 97800 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Pain (1994)
|
Event Date 03/28/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Information was received from an unknown source regarding a patient who was implanted with an implantable neurostimulator (ins) for urinary dysfunction (incontinence, urgency, and/or frequency).It was reported that the patient was experiencing pain.On 2024-mar-28, met with patient at the alexandria office.Patient stated they were experiencing pain at the ipg site with the interstim device.No weight change from implant.No impedance issues. according to patient, they underwent botox treatment on (b)(6) 2024; pain at ipg site started on 2024-feb-18. patient described their pain as sharp and brief and occurs in the morning when they awake and walks to the bathroom and starts to get ready in the morning.Patient denied having any falls, infections.On 2024-mar-15, patient met with their physician, informed physician of their pain at the ipg site.Patient was directed to turn their stimulator off.Patient did not turn their stimulator off until (b)(6) 2024.After turning their stimulator off, patient stated the sharp pain at the ipg site lessened and there was no residual pain.Patient also noticed their bladder activity became more bothersome with the device off. discussed options with physician.Patient to be scheduled for pocket revision (move ipg from right side buttock to left side buttock).Sent patient home on program a.Patient to try programs a, b, c to observe efficacy of interstim and pain at ipg site.If patient observes improvement in her bladder activity with minimal discomfort at the ipg site, patient may not proceed with pocket revision.Device was explanted on (b)(6) 2024.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|